OneSource Specialty Pharma Limited (BOM:544292)

BOM:544292 Revenue

OneSource Specialty Pharma had revenue of 5.17B INR in the quarter ending September 30, 2026, with 37.64% growth. This brings the company's total for the last twelve months to 16.82B, up 10.54% year-over-year. In the fiscal year ending March 31, 2026, OneSource Specialty Pharma had annual revenue of 14.23B, down -1.49%.

• Revenue (ttm): 16.82B
• Revenue Growth: +10.54%
• P/S Ratio: 10.76
• Revenue / Employee: 10.05M
• Employees: 1,674
• Market Cap: 180.91B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• United States of America 4.93B 34.7%
• India 3.96B 27.9%
• Rest of The World 3.08B 21.7%
• Spain 1.54B 10.8%
• Ireland 699.56M 4.9%

Fiscal year ended Mar 31, 2026 See the full BOM:544292 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	14.23B	-215.98M	-1.49%
Mar 31, 2025	14.45B	12.73B	740.50%
Mar 31, 2024	1.72B	1.33B	344.07%
Mar 31, 2023	387.14M	-	-

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 29, 2026

Data Sources Report a data error